Kaplan-Meier curve showing time to culture conversion by cohort (n = 231).

<p>Kaplan-Meier curve showing time to culture conversion by cohort (n = 231).</p

Treatment success indicators by cohort (n = 231).

<p>CI = Confidence Interval, IQA = Internationally quality assured, IQR = Interquartile range</p><p>*Expressed as a percentage of patients who were smear-positive at treatment initiation (84 in the GLC group and 133 in the non-GLC group)</p><p>** Observations censored after 6 months (182.5 days); 66% converted by 6 months</p><p>† Data on weight gain at 6 months post treatment initiation available for 188 patients</p><p>Treatment success indicators by cohort (n = 231).</p

Patient characteristics at baseline by cohort (n = 231).

<p>IQA = Internationally quality assured; IQR = interquartile range; <i>PAS = Para aminosalicylic acid / Eto = Ethionamide / Cs = Cycloserine</i></p><p>*9 patients had no sputum smear result within 2 weeks of treatment initiation</p><p>Patient characteristics at baseline by cohort (n = 231).</p

Results of field X-ray screening by participant characteristics of participants to the national TB prevalence survey in Pakistan, 2010–2011.

<p>Results of field X-ray screening by participant characteristics of participants to the national TB prevalence survey in Pakistan, 2010–2011.</p

Flow Diagram of National Prevalence Survey of Pakistan, 2010–11.

<p>Flow Diagram of National Prevalence Survey of Pakistan, 2010–11.</p

Estimated prevalence-to-notification ratios, comparing the estimated prevalence of smear-positive TB with the notification of new-smear positive TB for the Pakistan National Tuberculosis Program, by sex, age group and province, 2011.

<p>Estimated prevalence-to-notification ratios, comparing the estimated prevalence of smear-positive TB with the notification of new-smear positive TB for the Pakistan National Tuberculosis Program, by sex, age group and province, 2011.</p

Results of screening by questionnaire and participant characteristics from the national TB prevalence survey in Pakistan, 2010–2011.

<p>Results of screening by questionnaire and participant characteristics from the national TB prevalence survey in Pakistan, 2010–2011.</p

Estimated prevalence of sputum smear-positive and bacteriologically positive TB among adults (≥15 years) in the national Pakistan prevalence survey, 2010–2011.

<p>Estimated prevalence of sputum smear-positive and bacteriologically positive TB among adults (≥15 years) in the national Pakistan prevalence survey, 2010–2011.</p

TB cases according to case definitions.

<p>TB cases according to case definitions.</p

Flow chart to explain the flow of patients in TB Reach project, Pakistan

<p>Flow chart to explain the flow of patients in TB Reach project, Pakistan</p